Skip to main content
Erschienen in: Journal of Genetic Counseling 5/2013

01.10.2013 | Original Research

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

verfasst von: Julia Fehniger, Feng Lin, Mary S. Beattie, Galen Joseph, Celia Kaplan

Erschienen in: Journal of Genetic Counseling | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Previous studies examining communication of BRCA1/2 results with relatives and family uptake of BRCA1/2 testing have sampled from predominantly white, high SES cohorts ascertained solely from tertiary care centers. No studies have focused on family communication and testing among relatives of diverse BRCA1/2 carriers. We conducted structured interviews with 73 BRCA1/2 carriers identified at a public hospital and a tertiary cancer center. We asked participants if each first- and second-degree relative was aware of their BRCA1/2 results and whether or not each relative had tested. Generalized estimating equations identified rates and predictors of family communication and testing. Participants disclosed their test results to 73 % of 606 eligible relatives and 31 % of 514 eligible relatives tested. Communication and testing rates were similar for relatives of participants from the public hospital and the tertiary cancer center. Hospital site was not a significant predictor of either result disclosure or relative uptake of testing. African American and Asian/Pacific Islander participants were significantly less likely to disclose their results to their relatives; relatives of African American participants were significantly less likely to test. Addressing these disparities will require further research into the best ways to facilitate family communication and counsel at-risk relatives of racially and socioeconomically diverse BRCA1/2 mutation carriers.
Literatur
Zurück zum Zitat Armstrong, K., Weber, B., Stopfer, J., Calzone, K., Putt, M., Coyne, J., & Schwartz, S. (2003). Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. American Journal of Medical Genetics, 117A, 154–160.PubMed Armstrong, K., Weber, B., Stopfer, J., Calzone, K., Putt, M., Coyne, J., & Schwartz, S. (2003). Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. American Journal of Medical Genetics, 117A, 154–160.PubMed
Zurück zum Zitat Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Journal of the American Medical Association, 293(14), 1729–1736.PubMedCrossRef Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Journal of the American Medical Association, 293(14), 1729–1736.PubMedCrossRef
Zurück zum Zitat Barlow-Stewart, K., Yeo, S. S., Meiser, B., et al. (2006). Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genetics in Medicine, 8(1), 24–31.PubMedCrossRef Barlow-Stewart, K., Yeo, S. S., Meiser, B., et al. (2006). Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genetics in Medicine, 8(1), 24–31.PubMedCrossRef
Zurück zum Zitat Berliner, J. L., & Fay, A. M. (2007). Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 16(3), 241–260.PubMedCrossRef Berliner, J. L., & Fay, A. M. (2007). Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 16(3), 241–260.PubMedCrossRef
Zurück zum Zitat Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., et al. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93(4), 257–263.PubMedCrossRef Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., et al. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93(4), 257–263.PubMedCrossRef
Zurück zum Zitat Blandy, C., Chabal, F., Stoppa-Lyonnet, D., & Julian-Reynier, C. (2003). Testing participation in BRCA1/2 positive families: initiator role of index cases. Genetic Testing, 7(3), 225–233.PubMedCrossRef Blandy, C., Chabal, F., Stoppa-Lyonnet, D., & Julian-Reynier, C. (2003). Testing participation in BRCA1/2 positive families: initiator role of index cases. Genetic Testing, 7(3), 225–233.PubMedCrossRef
Zurück zum Zitat Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. Journal of the American Medical Association, 277(12), 997–1003.PubMedCrossRef Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. Journal of the American Medical Association, 277(12), 997–1003.PubMedCrossRef
Zurück zum Zitat Cheung, E. L., Olson, A. D., Yu, T. M., Han, P. Z., & Beattie, M. S. (2010). Communication of BRCA1/2 results and family testing in 1,103 high-risk women. Cancer Epidemiology, Biomarkers & Prevention, 19(9), 2211–2219.CrossRef Cheung, E. L., Olson, A. D., Yu, T. M., Han, P. Z., & Beattie, M. S. (2010). Communication of BRCA1/2 results and family testing in 1,103 high-risk women. Cancer Epidemiology, Biomarkers & Prevention, 19(9), 2211–2219.CrossRef
Zurück zum Zitat Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics, 116A, 11–19.PubMedCrossRef Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics, 116A, 11–19.PubMedCrossRef
Zurück zum Zitat De Leon Matsuda, M. L., Liede, A., Kwan, E., Mapua, C. A., Cutiongco, E. M., Tan, A., Borg, A., & Narod, S. A. (2002). BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. International Journal of Cancer, 98(4), 596–603.CrossRef De Leon Matsuda, M. L., Liede, A., Kwan, E., Mapua, C. A., Cutiongco, E. M., Tan, A., Borg, A., & Narod, S. A. (2002). BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. International Journal of Cancer, 98(4), 596–603.CrossRef
Zurück zum Zitat Domchek, S. M., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., & Isaacs, C. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. Journal of the American Medical Association, 304(9), 967–975.PubMedCrossRef Domchek, S. M., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., & Isaacs, C. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. Journal of the American Medical Association, 304(9), 967–975.PubMedCrossRef
Zurück zum Zitat Finlay, E., Stopfer, J. E., Burlingame, E., Evans, K. G., Nathanson, K. L., Weber, B. L., et al. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12(1), 81–92.PubMedCrossRef Finlay, E., Stopfer, J. E., Burlingame, E., Evans, K. G., Nathanson, K. L., Weber, B. L., et al. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12(1), 81–92.PubMedCrossRef
Zurück zum Zitat Haffty, B. G., Choi, D. H., Goyal, S., Silber, A., Ranieri, K., Matloff, E., et al. (2009). Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals of Oncology, 20(10), 1653–1659.PubMedCrossRef Haffty, B. G., Choi, D. H., Goyal, S., Silber, A., Ranieri, K., Matloff, E., et al. (2009). Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals of Oncology, 20(10), 1653–1659.PubMedCrossRef
Zurück zum Zitat Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap) — a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.PubMedCrossRef Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap) — a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.PubMedCrossRef
Zurück zum Zitat Harvey, S. L., Milne, R. L., McLachlan, S. A., Friedlander, M. L., Birch, K. E., & Weideman, P. (2011). Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families. Breast Cancer Research and Treatment, 130(3), 1057–1061.PubMedCrossRef Harvey, S. L., Milne, R. L., McLachlan, S. A., Friedlander, M. L., Birch, K. E., & Weideman, P. (2011). Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families. Breast Cancer Research and Treatment, 130(3), 1057–1061.PubMedCrossRef
Zurück zum Zitat Hughes, C., Lerman, C., Schwartz, M., Peshkin, B. N., Wenzel, L., Narod, S., et al. (2000). All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. American Journal of Medical Genetics, 107(2), 143–150.CrossRef Hughes, C., Lerman, C., Schwartz, M., Peshkin, B. N., Wenzel, L., Narod, S., et al. (2000). All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. American Journal of Medical Genetics, 107(2), 143–150.CrossRef
Zurück zum Zitat Hughes, C., Fasaye, G. A., LaSalle, V. H., & Finch, C. (2003). Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Education and Counseling, 51(2), 107–114.PubMedCrossRef Hughes, C., Fasaye, G. A., LaSalle, V. H., & Finch, C. (2003). Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Education and Counseling, 51(2), 107–114.PubMedCrossRef
Zurück zum Zitat Kardashian, A., Fehniger, J., Creasman, J., Cheung, E., & Beattie, M. S. (2012). Pilot study of the Sharing Risk Information Tool (ShaRIT) for families with hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice, 10, 4.PubMedCrossRef Kardashian, A., Fehniger, J., Creasman, J., Cheung, E., & Beattie, M. S. (2012). Pilot study of the Sharing Risk Information Tool (ShaRIT) for families with hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice, 10, 4.PubMedCrossRef
Zurück zum Zitat Kauff, N. D., Mitra, N., Robson, M. E., Hurley, K. E., Chuai, S., Goldfrank, D., et al. (2005). Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. Journal of the National Cancer Institute, 97(18), 1382–1384.PubMedCrossRef Kauff, N. D., Mitra, N., Robson, M. E., Hurley, K. E., Chuai, S., Goldfrank, D., et al. (2005). Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. Journal of the National Cancer Institute, 97(18), 1382–1384.PubMedCrossRef
Zurück zum Zitat Kurian, A. W., Gong, G. D., Chun, N. M., Mills, M. A., Staton, A. D., Kingham, K. E., et al. (2008). Performance of BRCA1/2 mutation prediction models in Asian Americans. Journal of Clinical Oncology, 26(29), 4752–4758.PubMedCrossRef Kurian, A. W., Gong, G. D., Chun, N. M., Mills, M. A., Staton, A. D., Kingham, K. E., et al. (2008). Performance of BRCA1/2 mutation prediction models in Asian Americans. Journal of Clinical Oncology, 26(29), 4752–4758.PubMedCrossRef
Zurück zum Zitat Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., West, D. W., et al. (2011). Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the breast cancer family registry. Journal of Clinical Oncology, 29(34), 4505–4509.PubMedCrossRef Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., West, D. W., et al. (2011). Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the breast cancer family registry. Journal of Clinical Oncology, 29(34), 4505–4509.PubMedCrossRef
Zurück zum Zitat Landsbergen, K., Verhaak, C., Kraaimaat, F., & Hoogerbrugge, N. (2005). Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Familial Cancer, 4(2), 115–119.PubMedCrossRef Landsbergen, K., Verhaak, C., Kraaimaat, F., & Hoogerbrugge, N. (2005). Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Familial Cancer, 4(2), 115–119.PubMedCrossRef
Zurück zum Zitat Lee, R., Beattie, M., Crawford, B., Mak, J., Stewart, N., Komaromy, M., et al. (2005). Recruitment, genetic counseling, and BRCA1/2 testing for underserved women at a public hospital. Genetic Testing, 9(4), 306–312.PubMedCrossRef Lee, R., Beattie, M., Crawford, B., Mak, J., Stewart, N., Komaromy, M., et al. (2005). Recruitment, genetic counseling, and BRCA1/2 testing for underserved women at a public hospital. Genetic Testing, 9(4), 306–312.PubMedCrossRef
Zurück zum Zitat Lerman, C., Hughes, C., Benkendorf, J. L., Biesecker, B., Kerner, J., Willison, J., et al. (1999). Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiology, Biomarkers & Prevention, 8(4 Pt 2), 361–367. Lerman, C., Hughes, C., Benkendorf, J. L., Biesecker, B., Kerner, J., Willison, J., et al. (1999). Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiology, Biomarkers & Prevention, 8(4 Pt 2), 361–367.
Zurück zum Zitat Lu, K., Kauff, N., Powell, C. B., Chen, L. M., Cass, I., Lancaster, J., et al. (2009). American college of obstetricians and gynecologists practice bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstetrics and Gynecology, 113(4), 957–966. Lu, K., Kauff, N., Powell, C. B., Chen, L. M., Cass, I., Lancaster, J., et al. (2009). American college of obstetricians and gynecologists practice bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstetrics and Gynecology, 113(4), 957–966.
Zurück zum Zitat MacDonald, D. J., Sarna, L., van Servellen, G., Bastani, R., Giger, J. N., & Weitzel, J. N. (2007). Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genetics in Medicine, 9(5), 275–282.PubMedCrossRef MacDonald, D. J., Sarna, L., van Servellen, G., Bastani, R., Giger, J. N., & Weitzel, J. N. (2007). Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genetics in Medicine, 9(5), 275–282.PubMedCrossRef
Zurück zum Zitat McGivern, B., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A., & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genetics in Medicine, 6(6), 503–509.PubMedCrossRef McGivern, B., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A., & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genetics in Medicine, 6(6), 503–509.PubMedCrossRef
Zurück zum Zitat Narod, S. (2009). Screening for BRCA1/2 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective. Salud Pública de México, 51(Suppl 2), S191–S196.PubMedCrossRef Narod, S. (2009). Screening for BRCA1/2 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective. Salud Pública de México, 51(Suppl 2), S191–S196.PubMedCrossRef
Zurück zum Zitat Nathanson, K. L., & Domchek, S. M. (2011). Therapeutic approaches for women predisposed to breast cancer. Annual Review of Medicine, 62, 295–306.PubMedCrossRef Nathanson, K. L., & Domchek, S. M. (2011). Therapeutic approaches for women predisposed to breast cancer. Annual Review of Medicine, 62, 295–306.PubMedCrossRef
Zurück zum Zitat National Comprehensive Cancer Network (2011) Genetic/familial high-risk assessment: breast and ovarian, version 1. Practice guidelines. Available at: http://www.nccn.org. Accessed 23 April 2012. National Comprehensive Cancer Network (2011) Genetic/familial high-risk assessment: breast and ovarian, version 1. Practice guidelines. Available at: http://​www.​nccn.​org. Accessed 23 April 2012.
Zurück zum Zitat Offit, K., Groeger, T., Turner, S., Wadsworth, E. A., & Weiser, M. A. (2004). The “duty to warn” a patient’s family members about hereditary disease risks. Journal of the American Medical Association, 292(12), 1469–1473.PubMedCrossRef Offit, K., Groeger, T., Turner, S., Wadsworth, E. A., & Weiser, M. A. (2004). The “duty to warn” a patient’s family members about hereditary disease risks. Journal of the American Medical Association, 292(12), 1469–1473.PubMedCrossRef
Zurück zum Zitat Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700–706.PubMedCrossRef Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700–706.PubMedCrossRef
Zurück zum Zitat Plon, S. E., Cooper, H. P., Parks, B., Dar, S., Kelly, P. A., Weinberg, A. D., et al. (2011). Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genetics in Medicine, 13(2), 148–154.PubMedCrossRef Plon, S. E., Cooper, H. P., Parks, B., Dar, S., Kelly, P. A., Weinberg, A. D., et al. (2011). Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genetics in Medicine, 13(2), 148–154.PubMedCrossRef
Zurück zum Zitat Ratnayake, P., Wakefield, C. E., Meiser, B., Suthers, G., Price, M. A., Duffy, J., et al. (2011). An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations. Familial Cancer, 10(1), 97–105.PubMedCrossRef Ratnayake, P., Wakefield, C. E., Meiser, B., Suthers, G., Price, M. A., Duffy, J., et al. (2011). An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations. Familial Cancer, 10(1), 97–105.PubMedCrossRef
Zurück zum Zitat Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009). Meta-analysis of risk-reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. Journal of the National Cancer Institute, 101(2), 80–87.PubMedCrossRef Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009). Meta-analysis of risk-reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. Journal of the National Cancer Institute, 101(2), 80–87.PubMedCrossRef
Zurück zum Zitat Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893–901.PubMedCrossRef Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893–901.PubMedCrossRef
Zurück zum Zitat Sermijn, E., Goelen, G., Teugels, E., Kaufman, L., Vonduelle, M., Neyns, B., et al. (2004). The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. Journal of Medical Genetics, 41(3), e23.PubMedCrossRef Sermijn, E., Goelen, G., Teugels, E., Kaufman, L., Vonduelle, M., Neyns, B., et al. (2004). The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. Journal of Medical Genetics, 41(3), e23.PubMedCrossRef
Zurück zum Zitat Susswein, L. R., Skrzynia, C., Lange, L. A., Booker, J. K., Graham, M. L., & Evans, J. P. (2008). Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. Journal of Clinical Oncology, 26(1), 32–36.PubMedCrossRef Susswein, L. R., Skrzynia, C., Lange, L. A., Booker, J. K., Graham, M. L., & Evans, J. P. (2008). Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. Journal of Clinical Oncology, 26(1), 32–36.PubMedCrossRef
Zurück zum Zitat Thompson, H. B., Jandorf, L., & Redd, W. (2003). Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina, and Caucasian women. Patient Education and Counseling, 51(3), 217–227.PubMedCrossRef Thompson, H. B., Jandorf, L., & Redd, W. (2003). Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina, and Caucasian women. Patient Education and Counseling, 51(3), 217–227.PubMedCrossRef
Zurück zum Zitat U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA1/2 mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Annals of Internal Medicine, 143(5), 355–361.CrossRef U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA1/2 mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Annals of Internal Medicine, 143(5), 355–361.CrossRef
Zurück zum Zitat Vos, J., Menko, F., Jansen, A. M., van Asperen, C. J., Stiggelbout, A. M., & Tibben, A. (2011). A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Familial Cancer, 10(1), 87–96.PubMedCrossRef Vos, J., Menko, F., Jansen, A. M., van Asperen, C. J., Stiggelbout, A. M., & Tibben, A. (2011). A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Familial Cancer, 10(1), 87–96.PubMedCrossRef
Zurück zum Zitat Wagner-Costalas, J., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., & Daly, M. B. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 119C, 11–18.PubMedCrossRef Wagner-Costalas, J., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., & Daly, M. B. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 119C, 11–18.PubMedCrossRef
Zurück zum Zitat Yoon, S. Y., Thong, M. K., Taib, N. A., Yip, C. H., & Teo, S. H. (2011). Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Familial Cancer, 10(2), 199–205.PubMedCrossRef Yoon, S. Y., Thong, M. K., Taib, N. A., Yip, C. H., & Teo, S. H. (2011). Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Familial Cancer, 10(2), 199–205.PubMedCrossRef
Metadaten
Titel
Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers
verfasst von
Julia Fehniger
Feng Lin
Mary S. Beattie
Galen Joseph
Celia Kaplan
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 5/2013
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-013-9592-4

Weitere Artikel der Ausgabe 5/2013

Journal of Genetic Counseling 5/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.